Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. QIAGEN N.V.
  6. News
  7. Summary
    QGEN   NL0012169213

QIAGEN N.V.

(QGEN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

QIAGEN NV : Berenberg reaffirms its Buy rating

06/11/2021 | 03:08am EDT

Scott Bardo from Berenberg retains his positive opinion on the stock with a Buy rating. The target price is reduced from EUR 56 to EUR 54.


ę MarketScreener with dpa-AFX Analyser 2021
All news about QIAGEN N.V.
06/17QIAGEN NVá : Deutsche Bank reiterates its Buy rating
MD
06/15QIAGEN Ná : Shareholder Davidson Kempner European Partners To Vote Against Chair..
MT
06/11QIAGEN N.V. : Release according to Article 40, Section 1 of the WpHG [the German..
EQ
06/11DGAP-PVRá : QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG ..
DJ
06/11Today on Wall Street: Much ado about nothing
06/11ANALYST RECOMMENDATIONS : Brown-Forman, Casey's General Stores, GameStop, Reckit..
06/11QIAGEN NVá : Berenberg reaffirms its Buy rating
MD
06/09ANALYST RECOMMENDATIONS : APA, Bank of America, Citigroup, Goldman Sachs, Visa....
06/08QIAGEN N.V. : Release according to Article 40, Section 1 of the WpHG [the German..
EQ
06/08DGAP-PVR : QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [..
DJ
More news
Financials (USD)
Sales 2021 2 265 M - -
Net income 2021 492 M - -
Net Debt 2021 887 M - -
P/E ratio 2021 21,6x
Yield 2021 -
Capitalization 10 683 M 10 683 M -
EV / Sales 2021 5,11x
EV / Sales 2022 5,07x
Nbr of Employees 5 750
Free-Float 98,2%
Chart QIAGEN N.V.
Duration : Period :
QIAGEN N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends QIAGEN N.V.
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 14
Average target price 57,46 $
Last Close Price 46,77 $
Spread / Highest target 53,9%
Spread / Average Target 22,9%
Spread / Lowest Target -12,3%
EPS Revisions
Managers and Directors
NameTitle
Thierry Bernard Chief Executive Officer & Managing Director
Roland Sackers Chief Financial Officer & Managing Director
Lawrence A. Rosen Chairman-Supervisory Board
Barthold Piening Senior Vice President & Head-Global Operations
Metin Colpan Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
QIAGEN N.V.-11.50%10 683
MODERNA, INC.93.81%81 297
LONZA GROUP AG15.68%53 313
IQVIA HOLDINGS INC.37.47%47 206
CELLTRION, INC.-25.07%32 426
SEAGEN INC.-12.42%27 835